The investigators propose in this trial to test a hepatic chemotherapy, consisting of the
hepatic intra-arterial injection Idarubicin, emulsified with Lipiodol, lipid vector, without
embolization in the treatment of non-metastatic, unresectable hepatocellular carcinoma on
cirrhosis with Child-Pugh A/B7.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.